Page 6 - 《中国药房》2024年12期
P. 6
Clinical observation of camrelizumab combined with sorafenib in the treatment of advanced liver cancer ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ ZOU Yubin，YANG Ling，XIAO Chijin （1522）
Pharmaceutical care of reactivating anthracycline chemotherapy in a patient with advanced breast cancer combined
with thyroid cancer ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ ZHANG Guangquan，LU Qi，YAN Dan，XU Silu （1527）
Pharmaceutical care for a patient with rhino-orbito-cerebral mucormycosis ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ WU Xia，ZHAO Yinlong，ZHANG Zhiqing，DONG Weichong （1533）
Adverse reactions of the digestive system caused by glucagon-like peptide-1 receptor agonists ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ LU Chunxiao，LU Changfei，ZHANG Huaqi，LIU Wenwen，CUI Xiaokang （1539）
CHINA PHARMACY （Semimonthly）
Founded in January 1990 Postal Address
Vol.35， No.12， Jun. 2024 129 Daping Main Street，Yuzhong District，Chongqing
Total No.774 Published on Jun. 30，2024 400042，China
Phone
Responsible Institution +86-23-63830521；+86-23-63830907；+86-23-68586727；
National Health Commission，P.R. China +86-23-68586827
Sponsored by E-mail
Chinese Hospital Association info@china-pharmacy.com
Chongqing University Cancer Hospital Website
Undertaken by http：//www.china-pharmacy.com
Journal Center of Chongqing University Cancer Hospital Online Submission
Published by http：//user.china-pharmacy.com
China Pharmacy Editorial Department Printed by
Director of Editorial Commission Chongqing Changhong Printing Co.， Ltd.
TIAN Jiazheng Distributed by
Executive Deputy Director of Editorial Commission China： Chongqing Branch of China Post Group Co.， Ltd.
WU Yongzhong （Code No.78-33）
Deputy Director of Editorial Commission Overseas： China International Book Trading Corporation
WANG Ying （Code No.4703SM）
Chief of Journal Center Subscription Rates
ZOU Xiaoyong CNY 15 per issue；CNY 360 per annum
Editor-in-Chief CSSN ISSN 1001-0408
HU Xin CN 50-1055/R
Deputy Editor-in-Chief CODEN
LENG Huaiming；ZOU Xiaoyong ZYHAA4
Chief Editor Perennial Legal Counsel
ZHANG Jian Chongqing Huali Wantao Law Firm
